Tetrabenazine-d6
Tetrabenazine-d6 (Deutetrabenazine) is a deuterium-labled Tetrabenazine , is the first deuterium approved worldwide for the research of Huntington's disease, or other hyperkinetic movement disorders[1].
Product Specifications
CAS Number
1392826-25-3
Product Name Alternative
Deutetrabenazine; Ro 1-9569-d6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Monoamine Transporter
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Purity
99.0
Solubility
10 mM in DMSO|DMSO : 33.33mg/mL (ultrasonic) |H2O : 0.1mg/mL (ultrasonic)
Smiles
O=C1[C@H](CC(C)C)CN2CCC3=CC(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])C=C3[C@@]2([H])C1
Molecular Formula
C19H21D6NO3
Molecular Weight
323.46
Precautions
H302, H315, H319, H335
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2408-100 1x 100 µL
CD14 (Monocyte / Macrophage Marker) (LPSR/2408), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880963-100 1x 100 µL
CD147 (BSG/963), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 